Screener
CytomX Therapeutics CTMX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's other non-current assets?
- CytomX Therapeutics (CTMX) reported other non-current assets of $31K in Q2 2026.
- How has CytomX Therapeutics's other non-current assets changed year-over-year?
- CytomX Therapeutics's other non-current assets decreased by 44.6% year-over-year, from $56K to $31K.
- What is the long-term trend for CytomX Therapeutics's other non-current assets?
- Over 5 years (2020 to 2025), CytomX Therapeutics's other non-current assets has grown at a -57.3% compound annual growth rate (CAGR), from $2.17M to $31K.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about CytomX Therapeutics's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude